154 related articles for article (PubMed ID: 33954928)
1. Identification of mutant K-RAS in pituitary macroadenoma.
Aran V; Heringer M; da Mata PJ; Kasuki L; Miranda RL; Andreiuolo F; Chimelli L; Filho PN; Gadelha MR; Neto VM
Pituitary; 2021 Oct; 24(5):746-753. PubMed ID: 33954928
[TBL] [Abstract][Full Text] [Related]
2. The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine.
Patek CE; Arends MJ; Rose L; Luo F; Walker M; Devenney PS; Berry RL; Lawrence NJ; Ridgway RA; Sansom OJ; Hooper ML
BMC Gastroenterol; 2008 Jun; 8():24. PubMed ID: 18554389
[TBL] [Abstract][Full Text] [Related]
3. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
4. Ras mutations in human pituitary tumors.
Karga HJ; Alexander JM; Hedley-Whyte ET; Klibanski A; Jameson JL
J Clin Endocrinol Metab; 1992 Apr; 74(4):914-9. PubMed ID: 1312542
[TBL] [Abstract][Full Text] [Related]
5. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation.
Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ
J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880
[TBL] [Abstract][Full Text] [Related]
6. Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism.
van Wijk PA; Rijnberk A; Croughs RJ; Meij BP; van Leeuwen IS; Sprang EP; Mol JA
J Endocrinol Invest; 1997 Jan; 20(1):1-7. PubMed ID: 9075064
[TBL] [Abstract][Full Text] [Related]
7. H-ras mutations in human pituitary carcinoma metastases.
Pei L; Melmed S; Scheithauer B; Kovacs K; Prager D
J Clin Endocrinol Metab; 1994 Apr; 78(4):842-6. PubMed ID: 8157709
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features.
Harada K; Hiraoka S; Kato J; Horii J; Fujita H; Sakaguchi K; Shiratori Y
Br J Cancer; 2007 Nov; 97(10):1425-31. PubMed ID: 17923875
[TBL] [Abstract][Full Text] [Related]
9. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.
Shibata D; Schaeffer J; Li ZH; Capella G; Perucho M
J Natl Cancer Inst; 1993 Jul; 85(13):1058-63. PubMed ID: 8515492
[TBL] [Abstract][Full Text] [Related]
10. RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.
Normanno N; Esposito Abate R; Lambiase M; Forgione L; Cardone C; Iannaccone A; Sacco A; Rachiglio AM; Martinelli E; Rizzi D; Pisconti S; Biglietto M; Bordonaro R; Troiani T; Latiano TP; Giuliani F; Leo S; Rinaldi A; Maiello E; Ciardiello F;
Ann Oncol; 2018 Jan; 29(1):112-118. PubMed ID: 28950295
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping.
Beau-Faller M; Legrain M; Voegeli AC; Guérin E; Lavaux T; Ruppert AM; Neuville A; Massard G; Wihlm JM; Quoix E; Oudet P; Gaub MP
Br J Cancer; 2009 Mar; 100(6):985-92. PubMed ID: 19293811
[TBL] [Abstract][Full Text] [Related]
12. K-RAS-2 gene mutations as predictors of metachronous colorectal adenomas.
Nusko G; Sachse R; Mansmann U; Wittekind C; Hahn EG
Scand J Gastroenterol; 1997 Oct; 32(10):1035-41. PubMed ID: 9361177
[TBL] [Abstract][Full Text] [Related]
13. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110
[TBL] [Abstract][Full Text] [Related]
14. The Krüppel-like transcription factor 6 gene in sporadic pituitary tumours.
Vax VV; Gueorguiev M; Dedov II; Grossman AB; Korbonits M
Endocr Relat Cancer; 2003 Sep; 10(3):397-402. PubMed ID: 14503916
[TBL] [Abstract][Full Text] [Related]
15. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique.
Levi S; Urbano-Ispizua A; Gill R; Thomas DM; Gilbertson J; Foster C; Marshall CJ
Cancer Res; 1991 Jul; 51(13):3497-502. PubMed ID: 1675933
[TBL] [Abstract][Full Text] [Related]
16. ["Field cancerization"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].
Aivado M; Gynes M; Gorelov V; Schmidt WU; Röher HD; Goretzki PE
Chirurg; 2000 Oct; 71(10):1230-4; discussion 1234-5. PubMed ID: 11077584
[TBL] [Abstract][Full Text] [Related]
17. The c-erbB-2/neu proto-oncogene in human pituitary tumours.
Ezzat S; Zheng L; Smyth HS; Asa SL
Clin Endocrinol (Oxf); 1997 May; 46(5):599-606. PubMed ID: 9231056
[TBL] [Abstract][Full Text] [Related]
18. Wild-type K-ras has a tumour suppressor effect on carcinogen-induced murine colorectal adenoma formation.
Luo F; Poulogiannis G; Ye H; Hamoudi R; Dong G; Zhang W; Ibrahim AE; Arends MJ
Int J Exp Pathol; 2014 Feb; 95(1):8-15. PubMed ID: 24354449
[TBL] [Abstract][Full Text] [Related]
19. p53 gene mutations in pituitary adenomas: rare events.
Levy A; Hall L; Yeudall WA; Lightman SL
Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
[TBL] [Abstract][Full Text] [Related]
20. Analysis of K-ras codon 12 mutation in flat and nodular variants of serrated adenoma in the colon.
Higashidani Y; Tamura S; Morita T; Tadokoro T; Yokoyama Y; Miyazaki J; Yang Y; Takeuchi S; Taguchi H; Onishi S
Dis Colon Rectum; 2003 Mar; 46(3):327-32. PubMed ID: 12626907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
